These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34523112)

  • 1. Gut Microbiota is an Important Source of Bacteriocins and Their In Situ Expression Can Be Explored for Treatment of Bacterial Infections.
    Drider D
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1759-1765. PubMed ID: 34523112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptide production in response to gut microbiota imbalance.
    Cardoso MH; Meneguetti BT; Oliveira-Júnior NG; Macedo MLR; Franco OL
    Peptides; 2022 Nov; 157():170865. PubMed ID: 36038014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food and gut originated bacteriocins involved in gut microbe-host interactions.
    Teng K; Huang F; Liu Y; Wang Y; Xia T; Yun F; Zhong J
    Crit Rev Microbiol; 2023 Aug; 49(4):515-527. PubMed ID: 35713699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocins - a viable alternative to antibiotics?
    Cotter PD; Ross RP; Hill C
    Nat Rev Microbiol; 2013 Feb; 11(2):95-105. PubMed ID: 23268227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swapping the roles of bacteriocins and bacteriophages in food biotechnology.
    Martínez B; García P; Rodríguez A
    Curr Opin Biotechnol; 2019 Apr; 56():1-6. PubMed ID: 30098459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.
    Pamer EG
    Science; 2016 Apr; 352(6285):535-8. PubMed ID: 27126035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.
    Ducarmon QR; Zwittink RD; Hornung BVH; van Schaik W; Young VB; Kuijper EJ
    Microbiol Mol Biol Rev; 2019 Aug; 83(3):. PubMed ID: 31167904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology.
    Mills S; Ross RP; Hill C
    FEMS Microbiol Rev; 2017 Aug; 41(Supp_1):S129-S153. PubMed ID: 28830091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity and dynamics of bacteriocins from human microbiome.
    Zheng J; Gänzle MG; Lin XB; Ruan L; Sun M
    Environ Microbiol; 2015 Jun; 17(6):2133-43. PubMed ID: 25346017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota as a source of novel antimicrobials.
    Garcia-Gutierrez E; Mayer MJ; Cotter PD; Narbad A
    Gut Microbes; 2019; 10(1):1-21. PubMed ID: 29584555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriocins: Recent Advances in its Application as an Antimicrobial Alternative.
    Fathizadeh H; Pakdel F; Saffari M; Esmaeili D; Heravi MM; Dao S; Ganbarov K; Kafil HS
    Curr Pharm Biotechnol; 2022; 23(8):1028-1040. PubMed ID: 34493194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Fecal Slurry Cultures to Study In Vitro Effects of Bacteriocins on the Gut Bacterial Populations of Infants.
    Umu ÖCO; Gueimonde M; Oostindjer M; Ovchinnikov KV; de Los Reyes-Gavilán CG; Arbulu S; Hernández PE; Martínez B; Diep DB; Salazar N
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):1218-1225. PubMed ID: 31788767
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Marra A; Hanson MA; Kondo S; Erkosar B; Lemaitre B
    mBio; 2021 Aug; 12(4):e0082421. PubMed ID: 34253067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demystifying Bacteriocins of Human Microbiota by Genome Guided Prospects: An Impetus to Rekindle the Antimicrobial Research.
    Suryaletha K; Savithri AV; Nayar SA; Asokan S; Rajeswary D; Thomas S
    Curr Protein Pept Sci; 2022; 23(12):811-822. PubMed ID: 36278460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
    Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Insights into Antimicrobial Resistance Traits of Commensal Human Gut Microbiota.
    Bag S; Ghosh TS; Banerjee S; Mehta O; Verma J; Dayal M; Desigamani A; Kumar P; Saha B; Kedia S; Ahuja V; Ramamurthy T; Das B
    Microb Ecol; 2019 Feb; 77(2):546-557. PubMed ID: 30009332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization resistance against multi-drug-resistant bacteria: a narrative review.
    Le Guern R; Stabler S; Gosset P; Pichavant M; Grandjean T; Faure E; Karaca Y; Faure K; Kipnis E; Dessein R
    J Hosp Infect; 2021 Dec; 118():48-58. PubMed ID: 34492304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.
    Gubatan J; Holman DR; Puntasecca CJ; Polevoi D; Rubin SJ; Rogalla S
    World J Gastroenterol; 2021 Nov; 27(43):7402-7422. PubMed ID: 34887639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis.
    Tavoukjian V
    J Hosp Infect; 2019 Jun; 102(2):174-188. PubMed ID: 30926290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.